← Open Payments lookup

JENNIFER O'BRIEN: Open Payments

NPI 1770125833 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$881 in 25 payments from 10 companies in 2025. Trend: 2023 $73 · 2024 $262 · 2025 $881

Food & beverage: $881
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.5$329
Neurocrine BioSciences, Inc.9$265
Teva Pharmaceuticals USA, Inc.4$125
Axsome Therapeutics, Inc.1$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Otsuka America Pharmaceutical, Inc.1$24
Bayer Healthcare Pharmaceuticals Inc.1$22
Alkermes, Inc.1$21
Vanda Pharmaceuticals Inc.1$20
Merck Sharp & Dohme LLC1$15

Products named: INGREZZA, COBENFY, OPDIVO, AUSTEDO XR, Auvelity, CAPLYTA, UZEDY, REXULTI.

Industry payments across NJ — which companies pay providers there.